Bank of Montreal
RNXT icon

Bank of Montreal’s RenovoRx RNXT Stock Holding History

Bank of Montreal’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-975,000
Closed -$1.03M – 3884
2024
Q3 		$1.03M Buy
+975,000
New +$1.09M ﹤0.01% 2021
2023
Q2 		– Sell
-975,000
Closed -$5.41M – 4248
2023
Q1 		$5.41M Buy
+975,000
New +$3.43M ﹤0.01% 1202

Other funds holding RNXT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.41B AUM 27.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal's RNXT Position: Q4 2024 in Review

Bank of Montreal sold out of RenovoRx (RNXT) in Q4 2024, closing a stake of 975,000 shares — an estimated $1.03M sold.

Bank of Montreal first reported a position in RNXT in Q1 2023 and held it in 2 quarters. The position peaked at $5.41M in Q1 2023. 18 funds tracked by Wall St. Rank hold RNXT as of Q4 2024.

  • Bank of Montreal reported no remaining RenovoRx position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 975,000 RenovoRx shares in Q4 2024, an estimated $1.03M.
  • Bank of Montreal first reported a position in RenovoRx in Q1 2023 and held it in 2 quarters.
  • Bank of Montreal's RenovoRx position peaked at $5.41M in Q1 2023.
  • 18 funds tracked by Wall St. Rank held RenovoRx as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.